Product Development
Gilead, Tango expand cancer partnership; plus Roche approval, Novavax COVID-19 efficacy study and G1, Myovant and PTC applications under review
Aug 18, 2020 | 1:52 AM GMT
Gilead takes stake in Tango, expands 2018 deal
Gilead Sciences Inc. (NASDAQ:GILD) million
